Also trades as: INXB (NASDAQ) · $vol 8M
INBX NASDAQ
Inhibrx Biosciences, Inc.
1W: -4.8%
1M: -3.9%
3M: +40.6%
YTD: +47.4%
1Y: +746.0%
$101.32
-9.25 (-8.37%)
Weekly Expected Move ±23.9%
$57
$83
$109
$135
$160
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-05-14
EPS
$-2.15
▲ Beat +9.3%
Revenue
—
Next Earnings
2026-08-19
EPS Estimate
$-2.28
Range: $-2.28 - $-2.28
Estimate vs Actual
Earnings Surprise History
6/19
EPS Beats
4/19
Revenue Beats
32%
EPS Beat Rate
21%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | quarter | 2027-06-30 | $— | $-1.86 | ▼ 1.86 | $— | $10,947,000 |
| 2026-05-18 | annual | 2026-12-31 | $-7.83 | $-9.23 | ▼ 1.41 | $4,300,000 | $4,300,000 |
| 2026-05-18 | annual | 2029-12-31 | $-1.99 | $-2.73 | ▼ 0.75 | $202,557,500 | $202,557,500 |
| 2026-05-18 | annual | 2030-12-31 | $3.39 | $2.76 | ▼ 0.63 | $353,603,500 | $353,603,500 |
| 2026-05-18 | quarter | 2027-12-31 | $— | $-1.22 | ▼ 1.22 | $— | $21,812,000 |
| 2026-05-18 | quarter | 2026-09-30 | $-2.02 | $-2.43 | ▼ 0.41 | $1,900,000 | $1,900,000 |
| 2026-05-18 | quarter | 2027-03-31 | $— | $-1.83 | ▼ 1.83 | $— | $9,578,000 |
| 2026-05-18 | quarter | 2026-12-31 | $-2.21 | $-2.50 | ▼ 0.29 | $2,400,000 | $2,400,000 |
| 2026-05-18 | annual | 2027-12-31 | $-5.61 | $-6.53 | ▼ 0.92 | $57,217,000 | $57,217,000 |
| 2026-05-18 | annual | 2028-12-31 | $-3.56 | $-3.98 | ▼ 0.42 | $131,347,500 | $131,347,500 |
| 2026-05-18 | quarter | 2027-09-30 | $— | $-1.39 | ▼ 1.39 | $— | $17,997,000 |
| 2026-05-18 | quarter | 2026-06-30 | $-1.90 | $-2.28 | ▼ 0.38 | $— | $— |
| 2026-04-28 | quarter | 2026-03-31 | $-1.78 | $-1.68 | ▲ 0.10 | $— | $— |
| 2026-04-28 | quarter | 2026-06-30 | $-2.00 | $-1.90 | ▲ 0.10 | $— | $— |
| 2026-04-28 | annual | 2028-12-31 | $-3.13 | $-3.56 | ▼ 0.42 | $131,347,500 | $131,347,500 |
Earnings Call Transcripts
No transcripts available.